We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study of AC Followed by a Combination of Paclitaxel Plus Trastuzumab or Lapatinib or Both Given Before Surgery to Patients With Operable HER2 Positive Invasive Breast Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00486668
Recruitment Status : Active, not recruiting
First Posted : June 15, 2007
Last Update Posted : June 6, 2016
Sponsor:
Collaborator:
GlaxoSmithKline
Information provided by (Responsible Party):
NSABP Foundation Inc

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Active, not recruiting
  Primary Completion Date : June 2012
  Estimated Study Completion Date : March 2017